What does this research mean for the field?

Hemorrhagic complications and excessive hypoprothrombinemic effects of anticoagulant drugs can be effectively managed through appropriate drug selection, laboratory monitoring of clotting factors, and administration of reversal agents such as vitamin K1. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

November 1, 1955Annals of Internal Medicine

The Control of Excessive Effect by Anticoagulants

Q: What is the clinical evidence from this study?

Study design: Review. Population: Hemorrhage secondary to anticoagulant therapy. Intervention: Anticoagulants.

View Full Paper

Ask AI

Bookmark

Key result

Anticoagulant review outlines available drugs and key factors for controlling excessive effects including hemorrhage.

Design

Review

Authors

IDI F DUFF JGJohn R. GambleLincoln County Health Department PWP W WILLIS

Discussion

Member takes

Implication

Foundational monitoring and reversal principles endure; leaves open adaptation to current DOACs and specific antidotes.

Structured PICO

Intervention

Anticoagulants (including Dicumarol and heparin)

This 1955 review discusses the pharmacologic properties of available anticoagulants and the management of their primary complication, hemorrhage.

Cite This Study

DUFF et al. (1955) conducted a review in Hemorrhage secondary to anticoagulant therapy. Anticoagulants was evaluated. This report reviews the available anticoagulant drugs and factors important in controlling their excessive effects, including the complication of hemorrhage.

synapsesocial.com/papers/6aa53b903f91f0dc5278e660 https://doi.org/10.7326/0003-4819-43-5-955

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

The Control of Excessive Effect by Anticoagulants

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

The Control of Excessive Effect by Anticoagulants

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider